Literature DB >> 2912980

Purification of human transcription factor IIIA and its interaction with a chemically synthesized gene encoding human 5 S rRNA.

K H Seifart1, L Wang, R Waldschmidt, D Jahn, E Wingender.   

Abstract

Transcription factor IIIA (TFIIIA) was purified from cytoplasmic extracts of HeLa cells by developing a simple and efficient procedure employing phosphocellulose under widely differing ionic conditions followed by affinity chromatography on immobilized human 5 S genes. This procedure yielded a fraction containing human TFIIIA activity and a protein of 35 kDa as its major component. Moreover, we succeeded in renaturing the activity of human transcription factor IIIA (hTFIIIA) isolated after preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis and in identifying a polypeptide of 35 kDa with the transcription activity. This value differs from that reported for Xenopus TFIIIA. It could be demonstrated by footprinting analyses that hTFIIIA specifically binds to the internal control region of the human 5 S rRNA gene. The limits of protection slightly differ at the 3' border of the internal control region from those imprinted by Xenopus TFIIIA on the same gene. Comparative footprint analyses of hTFIIIA on the human and frog somatic 5 S rRNA gene, measured in titration, competition, and salt-stability experiments, demonstrated a higher affinity of the human factor to the homologous gene. These results, together with the difference in molecular mass of these functionally analogous proteins, reemphasize the importance of homologous systems for the analysis of mechanisms involved in gene regulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2912980

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Transcription efficiency of human polymerase III genes in vitro does not depend on the RNP-forming autoantigen La.

Authors:  S Weser; M Bachmann; K H Seifart; W Meissner
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

2.  Characterization of human 5S rRNA genes.

Authors:  P D Sørensen; S Frederiksen
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

3.  Human transcription factor IIIC contains a polypeptide of 55 kDa specifically binding to Pol III genes.

Authors:  H R Schneider; R Waldschmidt; K H Seifart
Journal:  Nucleic Acids Res       Date:  1990-08-25       Impact factor: 16.971

4.  Human transcription factors IIIC2 , IIIC1 and a novel component IIIC0 fulfil different aspects of DNA binding to various pol III genes.

Authors:  S Oettel; F Härtel; I Kober; S Iben; K H Seifart
Journal:  Nucleic Acids Res       Date:  1997-06-15       Impact factor: 16.971

5.  Presence of multiple species of polypeptides immunologically related to transcription factor TFIIIA in adult Xenopus tissues.

Authors:  W Yasui; M Ryoji
Journal:  Nucleic Acids Res       Date:  1989-07-25       Impact factor: 16.971

6.  Purification of human transcription factor IIIC and its binding to the gene for ribosomal 5S RNA.

Authors:  H R Schneider; R Waldschmidt; D Jahn; K H Seifart
Journal:  Nucleic Acids Res       Date:  1989-07-11       Impact factor: 16.971

7.  The activity of transcription factor PBP, which binds to the proximal sequence element of mammalian U6 genes, is regulated during differentiation of F9 cells.

Authors:  W Meissner; A Ahlers; K H Seifart
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

8.  Human TFIIIA alone is sufficient to prevent nucleosomal repression of a homologous 5S gene.

Authors:  W Stünkel; I Kober; M Kauer; G Taimor; K H Seifart
Journal:  Nucleic Acids Res       Date:  1995-01-11       Impact factor: 16.971

9.  Human transcription factor IIIC binds to its cognate promoter sequences in a metal coordinated fashion.

Authors:  R Waldschmidt; H R Schneider; K H Seifart
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

Review 10.  Transcription factor IIIA (TFIIIA): an update.

Authors:  B S Shastry
Journal:  Experientia       Date:  1993-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.